Daptomycin labels and packages

Jump to navigation Jump to search
Daptomycin
CUBICIN ® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

CUBICIN is a registered trademark of Cubist Pharmaceuticals, Inc. All other trademarks are property of their respective owners.

Manufactured for:

Cubist Pharmaceuticals, Inc. Lexington, MA 02421 USA

April 2013 (1004-12)

PRINCIPAL DISPLAY PANEL - 500 mg Vial 500 mg

CUBICIN® (daptomycin for injection)

For intravenous use only Single use only Rx only

PRINCIPAL DISPLAY PANEL - 1 Vial Carton NDC 67919-011-01

One single-use vial 500 mg

CUBICIN® (daptomycin for injection)

For intravenous use only

Rx only

CUBIST Cubist Pharmaceuticals, Inc. Lexington, MA 02421 USA


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021572s033lbl.pdf